{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:11:47Z","timestamp":1788786707628,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.cct.2012.08.009","type":"journal-article","created":{"date-parts":[[2012,8,19]],"date-time":"2012-08-19T18:01:42Z","timestamp":1345399302000},"page":"1132-1142","source":"Crossref","is-referenced-by-count":64,"title":["Antibiotic retreatment of Lyme disease in patients with persistent symptoms: A biostatistical review of randomized, placebo-controlled, clinical trials"],"prefix":"10.1016","volume":"33","clinical-trial-number":[{"clinical-trial-number":"nct00000938","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00001101","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Allison K.","family":"DeLong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Blossom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2012.08.009_bb0005","first-page":"MR000006","article-title":"Publication bias in clinical trials due to statistical significance or direction of trial results","author":"Hopewell","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cct.2012.08.009_bb0010","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1371\/journal.pmed.0050217","article-title":"Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation","volume":"5","author":"Rising","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.cct.2012.08.009_bb0015","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1001\/jama.2010.651","article-title":"Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes","volume":"303","author":"Boutron","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2012.08.009_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s100960000415","article-title":"Arthropod-borne spirochetoses: a historical perspective","volume":"20","author":"Burgdorfer","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cct.2012.08.009_bb0025","author":"Centers for Disease Control and Prevention (CDC)"},{"key":"10.1016\/j.cct.2012.08.009_bb0030","article-title":"Lyme borreliosis: Europe-wide coordinated surveillance and action needed?","volume":"11","author":"Smith","year":"2006","journal-title":"Euro Surveill"},{"key":"10.1016\/j.cct.2012.08.009_bb0035","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7326\/0003-4819-121-8-199410150-00002","article-title":"The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study","volume":"121","author":"Shadick","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cct.2012.08.009_bb0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF01064684","article-title":"The neuropsychiatric manifestations of Lyme borreliosis","volume":"63","author":"Fallon","year":"1992","journal-title":"Psychiatr Q"},{"key":"10.1016\/j.cct.2012.08.009_bb0045","first-page":"454","article-title":"Lyme disease: an infectious and postinfectious syndrome","volume":"21","author":"Asch","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cct.2012.08.009_bb0050","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.medmal.2008.11.012","article-title":"Efficacy of a long-term antibiotic treatment in patients with a chronic Tick Associated Poly-organic Syndrome (TAPOS)","volume":"39","author":"Clarissou","year":"2009","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.cct.2012.08.009_bb0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0002-9343(02)01440-7","article-title":"Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease","volume":"114","author":"Steere","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.cct.2012.08.009_bb0060","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199011223232102","article-title":"Chronic neurologic manifestations of Lyme disease","volume":"323","author":"Logigian","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cct.2012.08.009_bb0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.1988.tb31838.x","article-title":"Borrelia burgdorferi in the nervous system: the new \u201cgreat imitator\u201d","volume":"539","author":"Pachner","year":"1988","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cct.2012.08.009_bb0070","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/ije\/dyi129","article-title":"Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms","volume":"34","author":"Cairns","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.cct.2012.08.009_bb0075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1468-1331.2009.02756.x","article-title":"Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors","volume":"17","author":"Ljostad","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cct.2012.08.009_bb0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease","volume":"345","author":"Klempner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cct.2012.08.009_bb0085","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","article-title":"A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy","volume":"70","author":"Fallon","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.cct.2012.08.009_bb0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/518854","article-title":"Point: antibiotic therapy is not the answer for patients with persisting symptoms attributable to Lyme disease","volume":"45","author":"Auwaerter","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cct.2012.08.009_bb0095","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/518853","article-title":"Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with Lyme disease","volume":"45","author":"Stricker","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cct.2012.08.009_bb0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","article-title":"Lyme borreliosis: clinical case definitions for diagnosis and management in Europe","volume":"17","author":"Stanek","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cct.2012.08.009_bb0105","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cct.2012.08.009_bb0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/01.wnl.0000265517.66976.28","article-title":"Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"69","author":"Halperin","year":"2007","journal-title":"Neurology"},{"issue":"8\u201316","key":"10.1016\/j.cct.2012.08.009_bb0115","first-page":"e1","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cct.2012.08.009_bb0120","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","article-title":"Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.cct.2012.08.009_bb0125","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00019053-200018050-00001","article-title":"The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?","volume":"18","author":"Hays","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.cct.2012.08.009_bb0130","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10096-007-0340-2","article-title":"Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study","volume":"26","author":"Oksi","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cct.2012.08.009_bb0135","first-page":"489","article-title":"Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial","volume":"99","author":"Cameron","year":"2008","journal-title":"Minerva Med"},{"key":"10.1016\/j.cct.2012.08.009_bb0140","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.WNL.0000068030.26992.25","article-title":"Cognitive function in post-treatment Lyme disease: do additional antibiotics help?","volume":"60","author":"Kaplan","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.cct.2012.08.009_bb0145","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/1529-0131(200007)43:7<1478::AID-ANR10>3.0.CO;2-M","article-title":"Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis","volume":"43","author":"Kosinski","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cct.2012.08.009_bb0150","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0","volume":"45","author":"Angst","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cct.2012.08.009_bb0155","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1365-2036.2009.03966.x","article-title":"Evaluation of the meaningfulness of health-related quality of life improvements as assessed by the SF-36 and the EQ-5D VAS in patients with active Crohn's disease","volume":"29","author":"Coteur","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cct.2012.08.009_bb0160","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1046\/j.1532-5415.2002.50604.x","article-title":"Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials","volume":"50","author":"Regensteiner","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.cct.2012.08.009_bb0165","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1081-1206(10)63463-1","article-title":"Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids","volume":"76","author":"Okamoto","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.cct.2012.08.009_bb0170","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jama.1996.03540130037027","article-title":"Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. Results from the Medical Outcomes Study","volume":"276","author":"Ware","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2012.08.009_bb0175","series-title":"SF-36 physical and mental health summary scales: a user's manual","author":"Ware","year":"1994"},{"key":"10.1016\/j.cct.2012.08.009_bb0180","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/00005650-199811000-00008","article-title":"Changes in the SF-36 in 12 months in a clinical sample of disadvantaged older adults","volume":"36","author":"Wolinsky","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.cct.2012.08.009_bb0185","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00005650-199905000-00006","article-title":"Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life","volume":"37","author":"Wyrwich","year":"1999","journal-title":"Med Care"},{"key":"10.1016\/j.cct.2012.08.009_bb0190","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"},{"key":"10.1016\/j.cct.2012.08.009_bb0195","first-page":"72","article-title":"Cognitive processing speed in Lyme disease","volume":"12","author":"Pollina","year":"1999","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"10.1016\/j.cct.2012.08.009_bb0200","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1212\/WNL.43.6.1093","article-title":"Detection of Borrelia burgdorferi antigens in cerebrospinal fluid","volume":"43","author":"Coyle","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.cct.2012.08.009_bb0205","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2147\/IJGM.S23829","article-title":"Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease","volume":"4","author":"Stricker","year":"2011","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.cct.2012.08.009_bb0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/07853899909115982","article-title":"Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis","volume":"31","author":"Oksi","year":"1999","journal-title":"Ann Med"},{"key":"10.1016\/j.cct.2012.08.009_bb0215","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/infdis\/158.4.905","article-title":"Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis","volume":"158","author":"Schmidli","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cct.2012.08.009_bb0220","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF01645543","article-title":"Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis","volume":"17","author":"Preac-Mursic","year":"1989","journal-title":"Infection"},{"key":"10.1016\/j.cct.2012.08.009_bb0225","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/art.1780361118","article-title":"Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis","volume":"36","author":"Haupl","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cct.2012.08.009_bb0230","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF01710737","article-title":"Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings","volume":"21","author":"Strle","year":"1993","journal-title":"Infection"},{"key":"10.1016\/j.cct.2012.08.009_bb0235","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1128\/AAC.49.4.1294-1301.2005","article-title":"In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy","volume":"49","author":"Hunfeld","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cct.2012.08.009_bb0240","doi-asserted-by":"crossref","first-page":"e29914","DOI":"10.1371\/journal.pone.0029914","article-title":"Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection","volume":"7","author":"Embers","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cct.2012.08.009_bb0245","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/AAC.00788-09","article-title":"Ineffectiveness of tigecycline against persistent Borrelia burgdorferi","volume":"54","author":"Barthold","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cct.2012.08.009_bb0250","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1128\/AAC.01050-07","article-title":"Persistence of Borrelia burgdorferi following antibiotic treatment in mice","volume":"52","author":"Hodzic","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cct.2012.08.009_bb0255","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/JCM.35.1.111-116.1997","article-title":"Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment","volume":"35","author":"Straubinger","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cct.2012.08.009_bb0260","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2133.1996.tb06972.x","article-title":"Safety of long-term high-dose minocycline in the treatment of acne","volume":"134","author":"Goulden","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cct.2012.08.009_bb0265","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-122-2-199501150-00001","article-title":"Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group","volume":"122","author":"Tilley","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cct.2012.08.009_bb0270","series-title":"Bioterrorism and drug preparedness","article-title":"Safety of long term therapy with penicillin and penicillin derivatives","author":"Cooper","year":"2001"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714412002030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714412002030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T18:13:44Z","timestamp":1594577624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714412002030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1551714412002030"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2012.08.009","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}